Sabzevari Helen's Form 4 filing
Precigen, Inc. (PGEN) · filed Jul 1, 2026
- Accession no.
- 0000950103-26-009978
- Filed
- Jul 1, 2026, 6:19 PM ET
- Trade date
- Jun 29, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sabzevari HelenCIK 0001724195 | Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | MOption exerciseAcquired | +346,836 | $2.33 | +$808,127.88 | 4,115,708 | Direct | |
| Jun 29, 2026 | Common Stock | SSaleDisposed | −346,836 | $5.89 | −$2,042,864.04 | 3,768,872 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | MOption exerciseDisposed | −346,836 | $0.00 | $0 | 500,164 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.